ClariVest Asset Management’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$234 Hold
20
﹤0.01% 838
2024
Q2
$234 Hold
20
﹤0.01% 838
2024
Q1
$421 Hold
20
﹤0.01% 812
2023
Q4
$359 Hold
20
﹤0.01% 853
2023
Q3
$0 Sell
20
-37
-65% -$671 ﹤0.01% 832
2023
Q2
$1K Sell
57
-15,088
-100% -$291K ﹤0.01% 632
2023
Q1
$287K Buy
15,145
+43
+0.3% +$951 0.01% 414
2022
Q4
$342K Sell
15,102
-24
-0.2% -$543 0.02% 408
2022
Q3
$400K Sell
15,126
-42
-0.3% -$1.25K 0.02% 389
2022
Q2
$375K Hold
15,168
0.02% 413
2022
Q1
$504K Buy
15,168
+5,818
+62% +$162K 0.02% 383
2021
Q4
$305K Sell
9,350
-617
-6% -$21K 0.01% 466
2021
Q3
$418K Sell
9,967
-344
-3% -$12.4K 0.01% 453
2021
Q2
$400K Buy
10,311
+24
+0.2% +$858 0.01% 449
2021
Q1
$351K Sell
10,287
-600
-6% -$25.6K 0.01% 454
2020
Q4
$493K Sell
10,887
-14,860
-58% -$519K 0.02% 386
2020
Q3
$709K Sell
25,747
-1,160
-4% -$37.8K 0.02% 328
2020
Q2
$992K Sell
26,907
-717
-3% -$26.7K 0.03% 322
2020
Q1
$894K Buy
27,624
+57
+0.2% +$2.38K 0.03% 321
2019
Q4
$1.13M Sell
27,567
-18,333
-40% -$724K 0.03% 339
2019
Q3
$1.64M Sell
45,900
-600
-1% -$24.3K 0.04% 279
2019
Q2
$2.39M Sell
46,500
-300
-0.6% -$15K 0.05% 231
2019
Q1
$2.68M Sell
46,800
-3,362
-7% -$167K 0.05% 280
2018
Q4
$2.1M Buy
50,162
+19,381
+63% +$1.14M 0.05% 297
2018
Q3
$2.32M Sell
30,781
-819
-3% -$59K 0.04% 304
2018
Q2
$2.26M Buy
+31,600
New +$1.51M 0.04% 326
2018
Q1
Sell
-33,100
Closed -$1.1M 764
2017
Q4
$1.1M Buy
+33,100
New +$997K 0.02% 414

Other funds holding RGNX